Oncopeptides, Inc. (U.S.) Email Format
Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees
Oncopeptides, Inc. operates within the pharmaceutical manufacturing sector, focusing on developing therapies for difficult-to-treat hematological diseases. The company aims to provide treatment options driven by scientific research and innovation, with a mission that centers on offering new possibilities to patients, caregivers, and healthcare providers dealing with cancer. Its U.S. presence is headquartered in Waltham, Massachusetts, with additional footprint in California, and its global headquarters are in Stockholm, Sweden, reflecting a bi-national orientation and a broader development platform. Positioned in the specialty biopharma space, Oncopeptides concentrates on addressing unmet clinical needs in hematology. The organization serves a medical and professional audience that seeks advanced treatment options for challenging blood cancers, operating from multiple U.S. locations to support its activities in a major biotechnology corridor. The information indicates a formal corporate footprint in the Boston-area region to facilitate its U.S. operations and research collaborations.